Mallinckrodt Skips Bond Interest Bill While Mulling Options
Pharmaceutical giant Mallinckrodt PLC disclosed to regulators Thursday that it will skip interest payments due on $1.025 billion in senior secured note obligations as the company weighs options while under growing...To view the full article, register now.
Already a subscriber? Click here to view full article